BioRem (CVE:BRM) Trading Up 2.3% – Should You Buy?

BioRem Inc. (CVE:BRMGet Free Report)’s stock price was up 2.3% on Wednesday . The stock traded as high as C$3.08 and last traded at C$3.08. Approximately 68,545 shares traded hands during trading, an increase of 126% from the average daily volume of 30,386 shares. The stock had previously closed at C$3.01.

BioRem Stock Performance

The company has a market capitalization of C$46.94 million, a P/E ratio of 14.19 and a beta of 0.85. The company has a debt-to-equity ratio of 48.97, a current ratio of 1.57 and a quick ratio of 1.08. The company has a fifty day moving average price of C$2.65 and a two-hundred day moving average price of C$2.30.

BioRem (CVE:BRMGet Free Report) last announced its earnings results on Monday, August 26th. The company reported C$0.02 EPS for the quarter. BioRem had a return on equity of 59.68% and a net margin of 11.35%. The business had revenue of C$7.30 million for the quarter.

BioRem Company Profile

(Get Free Report)

BioRem Inc, a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers biofilters for the removal of odors, H2S, VOCs, and HAPs; and biotrickling filters for applications of high levels of H2S or other water-soluble VOCs.

Featured Articles

Receive News & Ratings for BioRem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRem and related companies with MarketBeat.com's FREE daily email newsletter.